Your browser doesn't support javascript.
loading
Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial.
Annane, Djillali; Pittock, Sean J; Kulkarni, Hrishikesh S; Pickering, Brian W; Khoshnevis, Matt R; Siegel, Jason L; Powell, Charles A; Castro, Pedro; Fujii, Tomoko; Dunn, Derek; Smith, Keisha; Mitter, Sanjay; Kazani, Shamsah; Kulasekararaj, Austin.
Afiliación
  • Annane D; Department of Intensive Care, Raymond Poincaré Hospital (Assistance Publique-Hôpitaux de Paris), Garches, France; School of Medicine Simone Veil, University of Versailles Saint Quentin, University Paris-Saclay, Versailles, France; FHU SEPSIS, University Paris-Saclay, INSERM, Garches, France.
  • Pittock SJ; Department of Neurology, Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.
  • Kulkarni HS; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
  • Pickering BW; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
  • Khoshnevis MR; Department of Medicine, Center for Critical Care, Houston Methodist Hospital, Houston, TX, USA.
  • Siegel JL; Department of Critical Care Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Powell CA; Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Castro P; Medical Intensive Care Unit, Hospital Clinic of Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Fujii T; Intensive Care Unit, Jikei University Hospital, Tokyo, Japan.
  • Dunn D; Alexion, AstraZeneca Rare Disease, Boston, MA, USA.
  • Smith K; Alexion, AstraZeneca Rare Disease, Boston, MA, USA.
  • Mitter S; Alexion, AstraZeneca Rare Disease, Boston, MA, USA.
  • Kazani S; Alexion, AstraZeneca Rare Disease, Boston, MA, USA.
  • Kulasekararaj A; Department of Haematological Medicine, King's College Hospital, National Institute of Health Research/Wellcome King's Clinical Research Facility and King's College London, London, UK. Electronic address: austin.kulasekararaj@nhs.net.
Lancet Respir Med ; 11(12): 1051-1063, 2023 Dec.
Article en En | MEDLINE | ID: mdl-36958364
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía / COVID-19 Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía / COVID-19 Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Respir Med Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido